{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:00:21Z","timestamp":1773280821300,"version":"3.50.1"},"reference-count":4,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.japh.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T03:42:19Z","timestamp":1592192539000},"page":"e76-e79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-1618","authenticated-orcid":false,"given":"Roger Iain","family":"Pritchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6828-907X","authenticated-orcid":false,"given":"Jamie","family":"Huff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.japh.2020.06.004_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/j.1875-9114.2011.01038.x","article-title":"Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus","volume":"32","author":"McFarland","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.japh.2020.06.004_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jama.2013.6549","article-title":"Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial","volume":"310","author":"Margolis","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.japh.2020.06.004_bib6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.sapharm.2017.10.011","article-title":"Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: a systematic review","volume":"14","author":"Niznik","year":"2018","journal-title":"Res Social Adm Pharm"},{"issue":"13","key":"10.1016\/j.japh.2020.06.004_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2146\/ajhp170633","article-title":"Impact of the clinical pharmacy specialist in telehealth primary care","volume":"75","author":"Litke","year":"2018","journal-title":"Am J Health Syst Pharm"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120302703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120302703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:48:15Z","timestamp":1761544095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120302703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1544319120302703"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.004","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}